-
- Miriam Merad
- Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
-
- Catherine A. Blish
- Department of Medicine and Program in Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
-
- Federica Sallusto
- Institute of Microbiology, ETH Zürich, 8093 Zürich, Switzerland.
-
- Akiko Iwasaki
- Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
抄録
<jats:p>Considerable research effort has been made worldwide to decipher the immune response triggered upon severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, identify the drivers of severe and fatal COVID-19, and understand what leads to the prolongation of symptoms after disease resolution. We review the results of almost 2 years of COVID-19 immunology research and discuss definitive findings and remaining questions regarding our understanding of COVID-19 pathophysiology. We discuss emerging understanding of differences in immune responses seen in those with and without Long Covid syndrome, also known as post-acute sequelae of SARS-CoV-2. We hope that the knowledge gained from this COVID-19 research will be applied in studies of inflammatory processes involved in critical and chronic illnesses, which remain a major unmet need.</jats:p>
収録刊行物
-
- Science
-
Science 375 (6585), 1122-1127, 2022-03-11
American Association for the Advancement of Science (AAAS)